NNB Nutrition CurcuPrime: The Pure Tetrahydrocurcumin (4-HC) Breakdown

Curcumin might be the most famous ingredient in natural health. It's the compound that gives turmeric its golden color, it's been the subject of thousands of studies, and it shows up in everything from joint formulas to longevity stacks.

Curcumin's problem has always been what happens after you swallow it. NNB Nutrition's CurcuPrime skips ahead and starts with tetrahydrocurcumin (4-HC), the white, non-staining metabolite your body makes from curcumin anyway. No black pepper extract required.

It also has a well-known weakness. Once you swallow it, your body starts converting it into other compounds almost immediately, so very little of the original molecule makes it into circulation. For years, the industry's answer has been to fight that process with absorption enhancers and delivery technologies.

CurcuPrime: A Different Kind of Curcumin (Tetrahydrocurcumin)

NNB Nutrition took a different route. If the body is going to transform curcumin anyway, why not start with one of the compounds it transforms into? CurcuPrime is NNB's purified tetrahydrocurcumin (4-HC), a reduced form of curcumin that's white instead of yellow, considerably more stable, and turns up in tissues where curcumin often doesn't.

We first covered CurcuPrime here in August 2020, and a lot has changed since then. Researchers have published the first human trial of oral 4-HC, a 90-day safety study in rats, and a wave of new reviews on how curcumin's metabolites influence metabolic, vascular, and gut-liver health. This updated breakdown brings it all together.

Here's the short version:

• It's pure 4-HC. CurcuPrime is a single compound rather than a blend of reduced curcuminoids.
• It's white and non-staining. That opens the door to powders, drinks, and foods where curcumin's yellow pigment would be a dealbreaker.
• It doesn't need black pepper extract. Since 4-HC is already the reduced form, CurcuPrime isn't built around piperine's absorption boost.
• Dosing is simple. NNB suggests 200mg per serving, taken twice daily.

Want a heads-up when new CurcuPrime research or products land? Sign up for alerts below, then let's dive into the updated science:

What Is Tetrahydrocurcumin (4-HC)?

Turmeric (Curcuma longa) gets most of its biological activity from three curcuminoids: curcumin and two minor relatives, demethoxycurcumin and bisdemethoxycurcumin. Curcumin dominates the research, and lab studies show it interacts with a huge range of transcription factors, inflammatory cytokines, protein kinases, and other enzymes.^[1]

Curcumin’s Absorption Problem

The trouble starts after you swallow it. Curcumin is rapidly metabolized into curcumin glucuronide, curcumin sulfate, 4-HC, and other minor metabolites, leaving it with extremely low oral bioavailability.^[2] In one human trial, a massive 3.6g oral dose of curcumin produced a plasma curcumin level of just 11.1nmol/L an hour later.^[3] That's simply... not a lot.

The classic workaround is black pepper extract. Its active compound, piperine, inhibits glucuronidation in the liver and intestinal wall, and in a well-known human study, adding 20mg of piperine to 2g of curcumin increased curcumin's bioavailability by 2000%.^[4]

That works, but it comes with a trade-off. Glucuronidation is one of the body's main detoxification pathways, and we'd rather not throttle it just to get curcumin into the bloodstream if there's a better option. That's where 4-HC comes in.

Where Tetrahydrocurcumin (4-HC) Comes From

Tetrahydrocurcumin is one of the compounds your body makes from curcumin. In mice, curcumin is first reduced to dihydrocurcumin and then to 4-HC, and both are subsequently converted to glucuronide conjugates for clearance.^[5]

A "suped up" version of curcumin is here, and there are some excellent new benefits it brings!

The same conversion happens in people. When researchers incubated curcumin with cell fractions from human intestine and liver, 4-HC was one of the metabolites produced, and human tissue reduced curcumin far more aggressively than rat tissue (18 times more in the intestine and 5 times more in the liver).^[6]

A White Form of Curcumin!

The "tetrahydro" in the name refers to four added hydrogen atoms. That change removes curcumin's α,β-unsaturated carbonyl group, and the resulting compound is white rather than yellow.^[3]

More Stable Than Curcumin

4-HC also holds together better. In a phosphate buffer at pH 7.2 and 37°C (close to the body's pH and temperature), 4-HC was more stable than curcumin.^[5] A later review compiled the half-lives: curcumin degraded with a half-life of 186 minutes in cell culture medium and 111 minutes in plasma, compared to 813 and 232 minutes for 4-HC.^[3]

Note, of course, that these are chemical stability measurements, not how long each compound will last in your body. But they help explain the next finding:

It Shows Up Where Curcumin Doesn’t

In one animal study, four weeks of a turmeric extract left measurable 4-HC (235ng per 100mg of tissue) in subcutaneous fat, with no detectable curcumin. And in mice given curcumin, 4-HC appeared in plasma after 80 minutes, while curcumin itself couldn't be detected.^[3]

Also known as curcuma longa, turmeric is the root where we get curcumin.

Newer work points in the same direction. Preclinical studies have found that long-term oral 4-HC reaches higher liver and blood concentrations (including its glucuronide and sulfate conjugates) than curcumin does, suggesting better absorption from the gut.^[7] A 2025 review adds that 4-HC and other structurally enhanced curcumin analogs showed better pharmacokinetic and tissue-targeting properties than curcumin in preclinical models.^[8]

That doesn't make 4-HC a perfectly absorbed molecule. A 2024 review notes that in rodent studies, 4-HC's own oral absorption can still be improved in absolute terms and differs between males and females, which is why researchers are developing new delivery systems for it.^[9] Compared to curcumin, though, it's a far better starting point.

CurcuPrime: Pure 4-HC From NNB

CurcuPrime is NNB Nutrition's branded tetrahydrocurcumin. NNB is the ingredient developer behind MitoBurn, GlucoVantage, and a long list of other branded ingredients (we told that story in The NNB Nutrition Story), and it positions CurcuPrime for cognitive health and focus, joint health, a healthy inflammatory response, and healthy aging.

NNB Nutrition's CurcuPrime is a purified tetrahydrocurcumin ingredient for the precision-targeted benefits discussed above - and it's non-staining!

Here's what sets it apart:

• It's 4-HC only. NNB specifies that CurcuPrime is free of tetrahydrodemethoxycurcumin and tetrahydrobisdemethoxycurcumin, the reduced forms of turmeric's two minor curcuminoids. That makes it a different product than "tetrahydrocurcuminoids", a mix produced by hydrogenating turmeric's full curcuminoid fraction (that blend is the version authorized as a novel food in the EU).^[10]
• It's white, flavorless, and non-staining. Curcumin's pigment stains capsules, equipment, clothes, and countertops, and it turns beverages yellow. NNB also reports improved water dispersibility and stability for ready-to-drink applications.
• It's quality-tested. NNB puts CurcuPrime through extensive testing to confirm purity and consistency.

Human Data: The 2025 Pilot Trial

Until recently, every published 4-HC study was done in cells or animals. That changed in 2025, when researchers at the First People's Hospital of Yunnan Province in China published the first clinical trial of oral 4-HC.

The randomized, open-label pilot enrolled 19 adults with moderate-to-severe major depressive disorder (a HAMD-17 score of 17 or higher), confirmed by two board-certified psychiatrists. Nine took the antidepressant escitalopram (10mg/day) alone, while 10 took escitalopram plus 200mg/day of 4-HC (a commercially available product, not CurcuPrime) for 29 days. Sixteen participants completed the study.^[7]

Curcumin metabolically converts to tetrahydrocurcumin via the NADPH-dependent curcumin/dihydrocurcumin reductase (CurA) enzyme. As pH increases (more alkalinity), curcumin becomes more red. But tetrahydrocurcumin is white!^[11]

Overall scores on the 17-item Hamilton depression scale (HAMD-17) improved in both groups, with no significant difference between them over 29 days. The item-by-item analysis did turn up one difference: the 4-HC group improved significantly more on the scale's gastrointestinal symptoms item (p=0.025).^[7]

The researchers also analyzed participants' blood. They identified 32 serum proteins that differed between groups, with 4-HC influencing neurodegenerative pathways, and three of those proteins (P4HB, C1QA, and CDH13) were restored in both the human participants and the study's mouse arm. In that mouse arm, 4-HC reversed anxiety- and depression-like behaviors in chronically stressed mice and shifted serum markers including TNF-α, IL-1β, and dopamine.^[7]

It's a small, short, open-label pilot, but it's a great human starting point. The authors, as always, called for more trials.

Tetrahydrocurcumin (4-HC) Benefits

Most 4-HC research comes from animal and cell studies, and many of those compared it head-to-head with curcumin at the same dose. Here's what they found.

• Blood Sugar and Insulin

  In a type 2 diabetes model (rats treated with streptozotocin and nicotinamide), oral 4-HC daily for 45 days significantly lowered blood glucose and raised plasma insulin, outperforming the same dose of curcumin. The researchers chose 80mg/kg because their earlier work showed it beat 20mg/kg and 40mg/kg.^[12]

  In a separate study of estrogen-deficient rats on a high-fat diet, 4-HC, but not curcumin, prevented glucose intolerance.^[13]

  

  Four routes by which curcumin reshapes fat tissue, from blocking adipocyte differentiation to browning white fat through PGC-1α, SIRT1, and UCP1.^[8]

  A 2026 review ties these findings together. Its authors concluded that curcumin's effects on glucose and lipid metabolism are closely linked to its reduced metabolites, including 4-HC, which act on the same core pathways as curcumin, such as PPARα, NF-κB, and PI3K-AKT.^[14]

• Healthy Blood Lipids

  The same research group then turned to blood lipids. In the diabetic rat model, giving tetrahydrocurcumin for 45 days significantly reduced serum and liver cholesterol, triglycerides, free fatty acids, phospholipids, VLDL, and LDL. It also lowered the activity of HMG-CoA reductase, the rate-limiting enzyme in cholesterol production, and pushed depressed HDL levels back toward normal. Once again, 4-HC outperformed curcumin at the same dose.^[15]

  

  Curcumin shifts the microbiome toward SCFA producers and supports tight junction proteins. Note the top right box, where gut microbes convert curcumin into tetrahydrocurcuminoids.^[8]

  Newer research adds a gut-liver angle. In mice fed a high-fat diet, 4-HC reduced liver fat, lowered the liver enzymes AST and ALT, reduced oxidative stress, and downregulated two key fat-building enzymes, SCD1 and DGAT1. It also reshaped the gut microbiome, lowering the Firmicutes-to-Bacteroidetes ratio and increasing short-chain fatty acids.^[16] A 2025 review frames curcumin and 4-HC as regulators of the "adipose tissue-gut-liver axis", while stressing that large, well-controlled human trials are still needed.^[8]

• Antioxidant Support

  Antioxidant activity is where 4-HC most clearly separates itself from curcumin. A detailed review comparing the two found that most studies show 4-HC has higher antioxidant activity. It outperformed curcumin at quenching free radicals and at inducing the antioxidant enzymes glutathione peroxidase, glutathione-S-transferase, and NADPH:quinone reductase, while curcumin behaved as both an antioxidant and a pro-oxidant.^[3]

  

  A clinical dose doesn't need a capsule anymore. NNB Nutrition's "Ready to Consume" concept builds around ingredients small enough to disappear into a gummy, a shot, or a snack.

  That review found the opposite pattern for molecular targets. In cell and molecular studies, curcumin binds and inhibits dozens of targets that 4-HC doesn't, including COX-2 and NF-κB. The two molecules overlap, but they aren't interchangeable.^[3] This is why you'll see them stacked together in premium formulas.

  In the diabetic rat study described above, antioxidant defenses were depressed and lipid-peroxidation markers were elevated. 4-HC substantially reversed this pattern, restoring liver and kidney SOD, catalase, glutathione peroxidase, glutathione-S-transferase, reduced glutathione, and vitamins C and E while lowering TBARS and hydroperoxides. Liver TBARS rose from 0.75 in healthy rats to 1.85 in diabetic controls, but fell to 1.06 with 4-HC versus 1.35 with curcumin (mM/100g tissue).^[12]

• Healthy Inflammatory Response

  If curcumin directly hits more inflammatory targets in the lab, you'd expect it to win in live animals, too. But it often doesn't! Researchers have suggested that curcumin's activity in the body is closely tied to its metabolites, given its own low stability and poor bioavailability.^[17]

  In a classic 1982 study using carrageenan-induced paw swelling in rats, 4-HC ranked as more potent than curcumin. It produced 56.6% inhibition at 30mg/kg, while curcumin needed 60mg/kg to reach its peak of 67%. Both lost effectiveness at higher doses, a reminder that more isn't always better.^[18]

  A 2018 mouse study dug deeper. 4-HC reduced ear and paw swelling in a dose-dependent manner, and at the higher dose it suppressed vascular leakage by 45.1%, compared to 40.0% for curcumin at an even higher dose. 4-HC significantly lowered tissue levels of IL-1β, IL-6, TNF-α, and prostaglandin E2, performing similarly to the anti-inflammatory drug indomethacin, and it was more effective than curcumin at inhibiting COX-2 expression and the NF-κB pathway via TAK1 inactivation.^[17]

  

  Tetrahydrocurcumin has a tremendous effect on Blood Glucose and Insulin.^[19]

  A 2023 lab study added nuance: 4-HC inhibited TNF-α and IL-6 production, but not prostaglandin E2.^[20]

• Joint Comfort

  Researchers compared curcumin and tetrahydrocurcumin in estrogen-deficient, high-fat-fed rats that received a knee injection to create osteoarthritis-like joint changes. At 0.4% of the diet, both compounds protected against joint symptoms and pain-related behaviors better than estradiol treatment, and both helped preserve articular cartilage. The improvements tracked with lower cartilage expression of MMP3, MMP13, TNF-α, IL-1β, and IL-6, and both compounds maintained lean mass and lowered fat mass as well as estradiol did.^[13]

• Vascular Function and Blood Pressure

  Several studies suggest tetrahydrocurcumin supports healthy blood vessel function through nitric oxide.

  In isolated rat aortas, homocysteine thiolactone impaired the vessels' ability to relax in response to the vasodilator carbachol. Pretreatment with 4-HC restored that relaxation, matching curcumin. The impairment traced back to reduced nitric oxide and increased free radicals, and the researchers linked 4-HC's protective effect to its antioxidant properties.^[21]

  In a three-week rat study, researchers drove up blood pressure with L-NAME, a compound that blocks nitric oxide production. Rats that also received 4-HC had significantly suppressed blood pressure increases, lower vascular resistance, and restored vascular responsiveness. 4-HC brought back eNOS protein expression and plasma nitrate/nitrite, reduced vascular superoxide, and raised blood glutathione, and its blood pressure effects appeared stronger than curcumin's.^[22]

  A 2026 cell study helped explain why. In human endothelial cells, tetrahydrocurcumin dose-dependently activated the PI3K/AKT pathway, which switched on eNOS and increased nitric oxide availability. Blocking PI3K or AKT shut the effect down completely, demonstrating that it was the mechanism it was working on.^[23]

• Liver and Kidney Markers

  In an eight-week animal model of chemically induced liver injury (via carbon tetrachloride), daily oral tetrahydrocurcumin reduced liver fibrosis more effectively than curcumin, based on tissue analysis, serum markers, collagen deposition, and fibrosis-related proteins such as α-SMA and TGF-β1. It worked by downregulating TGF-β1/Smad and MAPK signaling and suppressing autophagy in the liver's activated stellate cells.^[24]

  

  How curcumin acts in the liver, dialing down fat production through SREBP1 and ACC while pushing fatty acid oxidation via PPARα, CPT1, and AMPK.^[8]

  In diabetic rats, giving 4-HC for 45 days brought plasma total protein, albumin, and globulin back toward normal, reversed elevated liver and kidney marker enzymes, and returned urea, uric acid, and creatinine toward normal levels. 4-HC again showed a better protective effect than curcumin.^[25]

• Cognitive Support: Early Research

  NNB positions CurcuPrime for cognitive health and focus, largely through acetylcholine support. Acetylcholine is a key neurotransmitter for learning and memory, and the enzyme acetylcholinesterase (AChE) breaks it down.

  In a 2013 test-tube study, each tetrahydro curcuminoid inhibited AChE about twice as well as its curcuminoid counterpart. Unmodified tetrahydrocurcumin had an IC50 (the concentration needed to cut enzyme activity in half, so lower is better) of 41.16μM, which the authors considered modest next to the reference drug galanthamine (1.45μM).^[26]

  Beyond acetylcholinesterase, a 2024 review summarizes rodent research in models of restricted brain blood flow, brain injury, and chronic stress, where tetrahydrocurcumin influenced mitochondrial homeostasis, neuroinflammation, and antioxidant systems.^[9] The 2025 human pilot's serum protein findings point in a similar direction.^[7]

  Test-tube enzyme data doesn't show what an oral dose does in the brain, so treat the cognitive angle as promising early science. Still, it could be an alternative to huperzine A for those who don't like the ingredient.

Safety, Tolerability, and Regulatory Status

Tetrahydrocurcumin's safety data has improved considerably since our original article.

Incredible hypertension reversal in this study!^[27]

The key study is a 90-day subchronic toxicity study paired with a reproductive and developmental toxicity study in Wistar rats. Oral 4-HC at 100, 200, and 400mg/kg/day had no significant effect on any measured parameter in male or female rats, which put the no-observed-adverse-effect level (NOAEL) at 400mg/kg/day, the highest dose tested. That's ten times the 40mg/kg dose the same researchers identified as effective in their animal efficacy work.^[28]

Acute toxicity testing in mice put tetrahydrocurcumin's LD50 above 10,000mg/kg, with no deaths or abnormal behavior over 14 days of observation!^[17]

In the human pilot, the researchers didn't report any safety concerns with 200mg/day for 29 days alongside escitalopram, and none of the three dropouts were related to side effects (two left for travel, and one declined the final blood draw).^[7]

One word of warning for anyone on medication, though: a 2024 review notes that in preclinical studies, tetrahydrocurcumin influenced several drug-metabolizing cytochrome P450 enzymes, including inhibiting CYP2C9 and CYP3A4, which could affect how certain drugs are processed.^[9] If you take prescription medications, check with your doctor before adding CurcuPrime. The same goes if you're pregnant, nursing, or managing a health condition.

Regulatory Status Abroad

European regulators take a more conservative view. Working from a 90-day rat study and a reproductive toxicity screening test, the European Food Safety Authority (EFSA) applied standard uncertainty factors to derive a safe level of 2mg/kg/day for a tetrahydrocurcuminoid blend, or 140mg/day for a 70kg adult.^[10] The EU then authorized that blend as a novel food in 2022 at up to 140mg/day for adults, excluding pregnant and breastfeeding women.^[29] NNB's suggested use of 400mg/day is intended for the U.S. market, so brands selling into the EU or other novel food jurisdictions need to reduce the dose and/or get their own regulatory assessment.

How to Use CurcuPrime

Look at those triglycerides! Incredible lipid changes from 4-HC.^[19]

NNB's suggested use is 200mg per serving, two servings per day (400mg total), with flexible timing. For reference, the human pilot used 200mg/day, and 400mg/day sits well below the highest dose tested in the rat safety study.

Because CurcuPrime is white and flavorless, it works in capsules and powders as well as drinks and foods where curcumin's color and taste would get in the way. That fits with NNB's broader push to bring small-dose ingredients into foods and gummies. And since tetrahydrocurcumin is already the reduced form, there's no need to pair it with piperine.

Stacking CurcuPrime

NNB suggests pairing CurcuPrime with common weight loss and thermogenic ingredients, including two of its own:

• MitoBurn (L-BAIBA), NNB's highly soluble BAIBA ingredient, which we covered in MitoBurn in the Bottle
• ZinjaBurn (dehydrozingerone), the ginger-derived compound from our ZinjaBurn breakdown

For joint comfort formulas, CurcuPrime pairs naturally with Bounce-C, NNB's patented chondroitin sulfate oligosaccharide ingredient. Given tetrahydrocurcumin's cartilage findings above, it's a combination we'd like to see on more shelves.

CurcuPrime: Curcumin Without the Baggage

Curcumin's biggest limitation has always been what happens after you swallow it. CurcuPrime sidesteps much of that by starting with tetrahydrocurcumin, a metabolite your body already makes from curcumin, delivered in pure, white, non-staining form.

The research case has grown since we first covered it years ago. Animal studies show 4-HC matching or beating curcumin on blood sugar, lipids, antioxidant defenses, inflammatory response, vascular function, and liver markers, often at the same or lower doses. A 90-day rat study set a high safety ceiling, and the first human pilot found a significant improvement on its gastrointestinal symptom measure at 200mg/day.

What we know about curcumin, what's still missing, and the large standardized human trials researchers want next.^[8]

What's missing now is larger, placebo-controlled human trials, ideally using CurcuPrime itself and measuring the outcomes the animal research points toward: glucose control, blood lipids, and joint comfort. We'll update this article as that research and new CurcuPrime products arrive. Sign up below to get notified when they do: